ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Metabolic disease"

  • 2020 American Transplant Congress

    Domino Transplantation – Expanding the Liver Donor Pool to the Pediatric Recipient

    U. Ekong1, N. Yazigi1, K. Khan1, S. Kaufman1, K. Chapman2, E. Leon2, N. Ah Mew2, A. Kroemer1, R. Girlanda1, J. Hawksworth1, C. Matsumoto1, T. Fishbein1

    1MedStar Georgetown Transplant Institute, Washington, DC, 2Genetics, Children's National Hospital, Washington, DC

    *Purpose: Background: Maple syrup urine disease (MSUD) is an inherited autosomal recessive metabolic disorder of amino acid metabolism, caused by a defect of the branched-chain…
  • 2020 American Transplant Congress

    Sleeve Gastrectomy Compared with Gastric Bypass for Morbidly Obese Liver Transplant Candidates: A Decision Analysis

    R. A. Choudhury1, D. Yoeli1, G. Hoeltzel2, H. B. Moore1, H. Yaffe1, K. R. Dumon3, N. N. Williams3, P. L. Abt4, K. D. Conzen1, J. J. Pomposelli1, E. A. Pomfret1, T. L. Nydam1

    1Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Aurora, CO, 2Thomas Jefferson University Hospital, Philadelphia, PA, 3Department of Surgery, University of Pennsylvania Hospital, Philadelphia, PA, 4Department of Surgery- Division of Transplantation Surgery, University of Pennsylvania Hospital, Philadelphia, PA

    *Purpose: The use of bariatric surgery has increased for morbidly obese liver transplant candidates for whom placement on the waitlist is often restricted until they…
  • 2020 American Transplant Congress

    Long Term Outcome of Patients Transplanted for Non Alcoholic Steatohepatitis Related Cirrhosis

    W. Alhamoudi1, I. Salih2, S. Yousif2, M. Shawkat3, K. Bzeizi2, S. Alghamdi2, A. Albenmousa2, D. Broering2

    1Medicine, King Saud University, Riyadh, Saudi Arabia, 2Liver Transplant, King Faisal Specialist Hospital, Riyadh, Saudi Arabia, 3Internal Medicine, Minia University, Minia, Egypt

    *Purpose: Nonalcoholic fatty liver disease (NAFLD) has emerged as the most common chronic liver disease worldwide. Cirrhosis secondary to Nonalcoholic Steatohepatitis (NASH) is projected to…
  • 2020 American Transplant Congress

    Progression of Insulin Resistance after Liver Transplantation – Prospective Study

    I. Mikova1, D. Erhartova1, K. Dvorakova1, P. Sedivy2, M. Drobny2, M. Dezortova2, M. Hajek2, M. Cahová3, H. Dankova3, E. Sticova4, V. Lanska5, P. Trunecka1

    1Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 2Radiodiagnostic and Interventional Radiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 3Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 4Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 5Medical Statistics Unit, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

    *Purpose: Insulin resistance (IR) plays an important role in pathogenesis of nonalcoholic fatty liver disease (NAFLD) and other diseases. The data about prevalence and evolution…
  • 2020 American Transplant Congress

    A NASHional Crisis: Liver Transplantation Outcomes in Female Hispanics

    R. A. Sosa1, A. Q. Terry1, M. Rossetti1, F. M. Kaldas2, B. V. Naini1, J. Nevarez-Mejia1, V. M. Groysberg1, S. Younan2, R. W. Busuttil2, D. W. Gjertson1, J. W. Kupiec-Weglinski2, E. F. Reed1

    1Pathology and Lab Medicine, UCLA, Los Angeles, CA, 2Surgery, UCLA, Los Angeles, CA

    *Purpose: Obesity and metabolic syndrome have recently become an epidemic with Hispanics bearing a disproportionate burden. Non-alcoholic steatohepatitis (NASH) is a severe immune-mediated stage of…
  • 2019 American Transplant Congress

    The Comparison of Glycemic Profiles during Post-Operative Early Period between Liver and Kidney Transplantation Assessed by Continuous Glucose Monitoring System

    H. Yu1, H. Jin2, S. Lee2, J. Yang1, S. Park2, S. Ahn1, H. Hwang1

    1Surgery, Chonbuk National University Medical School and Hospital, Jeonju, Korea, Republic of, 2Internal Medicine, Chonbuk National University Medical School and Hospital, Jeonju, Korea, Republic of

    *Purpose: Newly developed hyperglycemia and worsening of previously well controlled glucose control are common after transplantation because of stressful condition and immunosuppressive agents including of…
  • 2019 American Transplant Congress

    Metabolic Liver Transplantation – Can We Afford It?

    N. Yazigi1, W. Fujiwara2

    1Transplant Institute, MedStar Georgetown University Hospital, Washigton, DC, 2Georgetown University Medical School, Washigton, DC

    *Purpose: Despite major improvement in medical and nutritional care of pediatric patients suffering from intoxication inherited metabolic disorders, their long term outcomes remain guarded. Liver…
  • 2019 American Transplant Congress

    Living Donor vs. Deceased Donor Liver Transplantation for Pediatric Patients with Metabolic Liver Disease

    G. Gu, Q. Xia

    Renji Hospital, Shanghai, China

    *Purpose: Liver transplantation has been accepted as the appropriate treatment option for pediatric metabolic liver disease and the most common methods used are LDLT and…
  • 2019 American Transplant Congress

    Metabolic Liver Transplant: A Single Cooperative 2002-2017

    N. Yazigi1, K. Chapman2

    1Transplantation, MedStar Georgetown University Hospital, Washigton, DC, 2Transplantation, Children's National Rare Disease Institute, Washington, DC

    *Purpose: Liver transplant (LT) can increase quality and quantity of life for patients with inherited metabolic diseases (IMDs) who suffer severe and unpredictable complications despite…
  • 2019 American Transplant Congress

    Pediatric Liver Transplantation for Metabolic Disorders without Intrinsic Liver Disease: A 25 Year Experience

    P. Vuong, L. Lee, N. Mineyev, S. Conlon, R. Shetty, W. Concepcion, C. A. Bonham, A. Gallo, T. Pham, S. Busque, M. L. Melcher, G. M. Enns, C. O. Esquivel

    Stanford University Medical Center, Palo Alto, CA

    *Purpose: Liver transplantation (LT) for acute and chronic end-stage-liver-disease is a well-accepted therapy in pediatrics. However, for children with metabolic disorders (MD) without intrinsic liver…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 8
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences